Phases I–III Clinical Trials Using Adult Stem Cells

Phases I–III Clinical Trials Using Adult Stem Cells

Saved in:

Bibliographic Details
Main Authors:	Jeffrey M. Gimble, Bruce A. Bunnell, Louis Casteilla, Jin Sup Jung, Kotaro Yoshimura
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.4061/2010/604713
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Obesity Enhances the Conversion of Adipose-Derived Stromal/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype
by: Amy L. Strong, et al.
Published: (2017-01-01)

PPARs, RXRs, and Stem Cells
by: Jeffrey M. Gimble, et al.
Published: (2007-01-01)

Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
by: Darin Zehrung, et al.
Published: (2024-11-01)

Phases 1–3 Clinical Trials Using Adult Stem Cells in Osteonecrosis and Nonunion Fractures
by: Jean-Philippe Hauzeur, et al.
Published: (2010-01-01)

Dissemination of trial results to participants in phase III pragmatic clinical trials: an audit of trial investigators intentions
by: Katie Gillies, et al.
Published: (2020-01-01)

Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt
by: Ronald T. Mitsuyasu, et al.
Published: (2011-01-01)

Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors
by: Tianyi Wang, et al.
Published: (2025-12-01)

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Steffen Borrmann, et al.
Published: (2008-11-01)

Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial
by: Jeffrey M. Saland, et al.
Published: (2024-07-01)

Survival-inferred fragility of statistical significance in phase III oncology trials
by: Alexander D. Sherry, et al.
Published: (2025-07-01)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.
by: Miranta Antoniou, et al.
Published: (2016-01-01)

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III
by: E. V. Akatova, et al.
Published: (2024-12-01)

THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)
by: E. L. Nasonov, et al.
Published: (2016-12-01)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
by: Peter Nash, et al.
Published: (2019-06-01)

Results from phase III clinical trials with radachlorine for photodynamic therapy of pre-cancer and early cancer of cervix
by: E. V. Filonenko, et al.
Published: (2015-09-01)

Phase I clinical trials in oncology
by: Prasanth Ganesan
Published: (2020-01-01)

Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics
by: Josephine Bourner, et al.
Published: (2025-02-01)

Allocating the Sample Size in Phase II and III Trials to Optimize Success Probability
by: Daniele De Martini
Published: (2014-11-01)

Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS
by: L. P. Ananyeva, et al.
Published: (2025-02-01)

Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials
by: Yu-Yun Shao, et al.
Published: (2025-01-01)

Application of allogeneic adult mesenchymal stem cells in the treatment of venous ulcers: A phase I/II randomized controlled trial protocol.
by: Víctor J Costela-Ruiz, et al.
Published: (2025-01-01)

THE EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR (ACELLBIA®) IN RHEUMATOID ARTHRITIS AS THE FIRST BIOLOGICAL AGENT: RESULTS OF PHASE III (ALTERRA) CLINICAL TRIAL
by: E. L. Nasonov, et al.
Published: (2017-09-01)

Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial
by: Thomas M. Polasek, et al.
Published: (2025-06-01)

A prospective multicenter phase III clinical trial evaluating the efficacy and safety of silk elastin sponge in patients with skin defects
by: Eiichi Sawaragi, et al.
Published: (2025-04-01)

Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugs
by: Melissa K. Shields, et al.
Published: (2025-06-01)

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
by: Patrick P J Phillips, et al.
Published: (2019-03-01)

Examining a Telemedicine-Based Virtual Reality Clinic in Treating Adults With Specific Phobia: Protocol for a Feasibility Randomized Controlled Efficacy Trial
by: Kaitlyn R Schuler, et al.
Published: (2025-04-01)

Application of the ESMO Magnitude of Clinical Benefit Scale to assess the clinical benefit of antibody drug conjugates in solid cancer: a systematic descriptive analysis of phase III and pivotal phase II trials
by: Yang Wang, et al.
Published: (2024-06-01)

Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial
by: Takuji Kawamura, et al.
Published: (2024-12-01)

Phase I Clinical Research of Jejunal Interposition in Adenocarcinoma of the Esophagogastric Junction II/III Proximal Gastrectomy
by: Kai Tao, et al.
Published: (2016-01-01)

Therapeutics for Sarcopenia and Functional Disabilities in Older Adults: A Review of Phase 4 Clinical Trials
by: Alorfi NM, et al.
Published: (2025-03-01)

Publisher Correction: Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugs
by: Melissa K. Shields, et al.
Published: (2025-07-01)

Broad-Spectrum Antibacterial Effects of Human Adipose-Derived Stromal Cells
by: Paul Monsarrat, et al.
Published: (2019-01-01)

Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy
by: Seok Jong Chung, et al.
Published: (2021-01-01)

Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta‐Epidemiological Analysis
by: Gabrielle Brown, et al.
Published: (2025-08-01)

Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial
by: Kelly Jones, et al.
Published: (2025-01-01)

Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials
by: Syrine Ben Dhia, et al.
Published: (2025-01-01)

Improving Stem Cell Clinical Trial Design and Conduct: Development of a Quality Assessment Tool for Stem Cell Clinical Trials
by: Yixuan Li, et al.
Published: (2020-01-01)

Study of the trial subjects’ protection aspects in Phase I clinical trials and bioequivalence studies
by: K. O. Zupanets, et al.
Published: (2016-03-01)

Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial
by: Mohammad Ali Sahraian, et al.
Published: (2024-10-01)